IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 185
Titolo Data di pubblicazione Autore(i) File
Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy 1-gen-2024 Bolcato, Matteo; Jommi, Claudio
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study 1-gen-2024 Cavallo, Maria Caterina; Cavazza, Marianna; Bonifazi, Francesca; Casadei, Beatrice; Cutini, Ilaria; Tonietti, Barbara; Saccardi, Riccardo; Zinzani, Pierluigi; Jommi, Claudio
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy 1-gen-2024 Rossini, Elvio Emanuele; Galeone, Carlotta; Lucchetti, Chiara; Jommi, Claudio
Content validity of the EQ-HWB and EQ-HWB-S in a sample of Italian patients, informal caregivers and members of the general public 1-gen-2024 Masutti, Sara; Falivena, Camilla; Purba, Fredrick Dermawan; Jommi, Claudio; Mukuria, Clara; Finch, Aureliano Paolo
Regional Formularies in Italy: current state and future perspectives 1-gen-2024 Bortolami, Alberto; Jommi, Claudio; Bresciani, Filippo; Piccoli, Luca; Sangiorgi, Elisa; Scroccaro, Giovanna
Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access 1-gen-2023 Giovannelli, Lorella; Bari, Elia; Jommi, Claudio; Tartara, Fulvio; Armocida, Daniele; Garbossa, Diego; Cofano, Fabio; Torre, Maria Luisa; Segale, Lorena
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy? 1-gen-2023 Drummond, Michael; Ciani, Oriana; Fornaro, Giulia; Jommi, Claudio; Dietrich, Eva Susanne; Espin, Jaime; Mossman, Jean; de Pouvourville, Gerard
The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency 1-gen-2023 Jommi, Claudio; Galeone, Carlotta
Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries 1-gen-2023 Canales Albendea, Miguel Á.; Canonico, Pier Luigi; Cartron, Guillaume; Deiters, Barthold; Jommi, Claudio; Marks, Reinhard; Rioufol, Catherine; Sancho Cia, Juan M.; Santoro, Armando; Wagner-Drouet, Eva M.
Do France, Germany, and Italy agree on the added therapeutic value of medicines? 1-gen-2023 Casilli, Giorgio; Lidonnici, Dario; Jommi, Claudio; De Nigris, Marika; Genazzani, Armando
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case 1-gen-2023 Tarantola, A.; Otto, M. H.; Armeni, P.; Costa, F.; Malandrini, F.; Jommi, C.
Vitiligo: Unmet Need, Management and Treatment Guidelines 1-gen-2023 Marzano, Angelo Valerio; Alberti-Violetti, Silvia; Maronese, Carlo Alberto; Avallone, Gianluca; Jommi, Claudio
EQ-5D-5L Population Norms for Italy 1-gen-2023 Meregaglia, Michela; Malandrini, Francesco; Finch, Aureliano Paolo; Ciani, Oriana; Jommi, Claudio
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care 1-gen-2023 Vingiani, Andrea; Agnelli, Luca; Duca, Matteo; Lorenzini, Daniele; Damian, Silvia; Proto, Claudia; Niger, Monica; Nichetti, Federico; Tamborini, Elena; Perrone, Federica; Piccolo, Alberta; Manoukian, Siranoush; Azzollini, Jacopo; Brambilla, Marta; Colombo, Elena; Lopez, Salvatore; Vernieri, Claudio; Marra, Francesca; Conca, Elena; Busico, Adele; Capone, Iolanda; Bozzi, Fabio; Angelini, Marta; Devecchi, Andrea; Salvatori, Rebecca; De Micheli, Valentina; Baggi, Anna; Pasini, Silvia; Jommi, Claudio; Ladisa, Vito; Apolone, Giovanni; De Braud, Filippo; Pruneri, Giancarlo
CAR T-Cell Therapies in Italy: Patient Access Barriers and Recommendations for Health System Solutions 1-gen-2022 Jommi, C.; Bramanti, S.; Pani, M.; Ghirardini, A.; Santoro, A.
The costs incurred by patients to get eligibility to PCSK9 treatment and one-year follow-up: the results of the PRIOR Study 1-gen-2022 Bertolani, A; Ravasio, R; Raimondo, P; Jommi, C
Drugs price and reimbursement regulation: comparators, endpoints and role of the cost-effectiveness 1-gen-2022 Jommi, Claudio; Apolone, Giovanni; Scroccaro, Giovanna; Acciai, Valentina; Addis, Antonio; Ardizzoni, Andrea; Bernardini, Renato; Bortolami, Alberto; Brigido, Alessia; Buzzetti, Giuliano; Canonico, Pier Luigi; Caprari, Francesca; Centanni, Stefano; Cernetti, Chiara; Cicchetti, Americo; Corsico, Giorgio; Damele, Francesco; De Braud, Filippo; Manurita, Sara; Mennini, Francesco Saverio; Olivi, Irene; Parretta, Federica; Pippo, Lara; Pulimeno, Stefania; Riccaboni, Massimo; Rossi, Giuseppe; Saleri, Cecilia; Sinibaldi, Alessandra; Spandonaro, Federico; Stefenoni, Cristian; Visentin, Elena; Viale, Pierluigi; Zapparelli, Giuseppina; Popoli, Patrizia
Faciliating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework 1-gen-2022 Whittal, A.; Jommi, C.; De Pouvourville, G.; Taylor, D.; Annemans, L.; Schoonaert, L.; Vermeersch, S.; Hutchings, A.; Patris, J.
An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration 1-gen-2022 Finch, Aureliano Paolo; Meregaglia, Michela; Ciani, Oriana; Roudijk, Bram; Jommi, Claudio
Unmet clinical need and new therapeutic options 1-gen-2022 Caprari, F.; Alfano, A.; Buzzetti, G.; Consoli, A.; De Braud, F.; Patarnello, F.; Pitrelli, A.; Riccaboni, M.; Rossi, G.; Samele, R.; Scaduto, D.; Viale, P.; Jommi, C.; Popoli, P.
Mostrati risultati da 1 a 20 di 185
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile